Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Cancer Biology & Medicine|January 20, 2025
Improving systemic delivery of oncolytic virus by cellular carriersZiyi Peng, Muhammad Kalim, Yong LuPreparative Biochemistry & Biotechnology|March 22, 2018
Polyclonal antibody production against rGPC3 and their application in diagnosis of hepatocellular carcinomaShenghao Wang, Muhammad Kalim, Keying Liang, et al.Chemical Biology & Drug Design|March 14, 2020
Programmed cell death ligand-1: A dynamic immune checkpoint in cancer therapyMuhammad Kalim, Muhammad Saleem Iqbal Khan, Jinbiao ZhanCytotechnology|May 18, 2019
Efficient development and expression of scFv recombinant proteins against PD-L1 surface domain and potency in cancer therapyMuhammad Kalim, Keying Liang, Muhammad Saleem Iqbal Khan, et al.Cancer Letters|October 19, 2024
Functional diversity and regulation of IL-9-producing T cells in cancer immunotherapyMuhammad Kalim, Rui Jing, Wei Guo, et al.Acta Crystallographica. Section E, Structure Reports Online|January 5, 2011
2-Propyl-4H-thia-zolo[3,2-a][1,3,5]triazine-4-thioneUzma Yunus, Muhammad Kalim Tahir, Moazzam Hussain Bhatti, et al.Acta Crystallographica. Section E, Structure Reports Online|January 5, 2011
Ethyl 4-(3-butyrylthio-ureido)benzoateSohail Saeed, Moazzam Hussain Bhatti, Muhammad Kalim Tahir, et al.Acta Crystallographica. Section E, Structure Reports Online|January 5, 2011
N-(Thia-zol-2-yl)acetamideUzma Yunus, Muhammad Kalim Tahir, Moazzam Hussain Bhatti, et al.Frontiers in Immunology|November 7, 2022
Bioengineering and computational analysis of programmed cell death ligand-1 monoclonal antibodyMuhammad Kalim, Hamid Ali, Ashfaq Ur Rehman, et al.Genetics and Molecular Biology|January 23, 2020
Engineered scPDL1-DM1 drug conjugate with improved in vitro analysis to target PD-L1 positive cancer cells and intracellular trafficking studies in cancer therapyMuhammad Kalim, Shenghao Wang, Keying Liang, et al.Pageof 3